Skip to main content

Animations

MJFF Publications

2721 - 2730 of 8471 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Depression and Parkinson's disease: a Chicken-Egg story
    Journal Name: AIMS Neuroscience
    Publisher: American Institute of Mathematical Sciences (AIMS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3934/neuroscience.2022027
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103144
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Distinct atrophy of septal nuclei in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171
    Citation Count: 1
  • Summary Details
    OPEN
    Title: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure Storage
    Journal Name: Computers, Materials & Continua
    Publisher: Tech Science Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.32604/cmc.2022.022028
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Drug News
    Journal Name: Nursing
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0c
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000525664
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis
    Journal Name: The International Journal of Biochemistry & Cell Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients
    Journal Name: Dementia and Geriatric Cognitive Disorders
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000525618
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Exploration of Protein Aggregations in Parkinson’s Disease Through Computational Approaches and Big Data Analytics
    Journal Name: Methods in Molecular Biology
    Publisher: Springer US
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-0716-1546-1_19
    Best OA location URL:
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.